(IN BRIEF) The GEMINI study, the largest of its kind, has revealed significant genetic overlaps in 72 long-term health conditions related to aging. Conducted by the University of Exeter Medical School and funded by the Medical Research Council and the … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Management, News, Science, Technology, United Kingdom
Tagged aging, B12 deficiency, BAAINBw, disease overlaps, Dr. Joao Delgado, eBioMedicine, GEMINI study, genetic analysis, genetic factors, genetic overlaps, health research, healthcare services, iron deficiency anaemia, long-term health conditions, Medical Research Council, multimorbidity, multimorbidity prevention, National Institute for Health Research, NIHR, patient records, Personalized Treatment, prevention, primary care, Professor Jane Masoli, treatment, University of Exeter Medical School
(IN BRIEF) Roche has announced that the FDA has expanded the approval of its PATHWAY® HER2/neu (4B5) Rabbit Monoclonal Primary Antibody test to identify HER2-ultralow status in HR-positive, HER2-negative metastatic breast cancer patients. This new approval offers a potential treatment … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Security & Safety, Switzerland, Technology
Tagged breast cancer, DESTINY-Breast06 trial, diagnostic solutions, Enhertu, FDA, FDA approval, HER2-Low, HER2-targeted therapy, HER2-Ultralow, HR-positive, metastatic breast cancer, PATHWAY HER2, Personalized Treatment, Roche, treatment options
(IN BRIEF) Researchers have identified the genetic variant HLA-DRB1*01:03, which is strongly linked to severe ulcerative colitis. About 3% of patients carry this variant, and of those, over 40% required major surgery within three years of diagnosis. (PRESS RELEASE) AALBORG, … Read the full press release
Posted in Business, Denmark, Education, Financial, Healthcare, Industrial, Investment, Management, News, Science, Technology
Tagged Aalborg University, Anne Krogh Nøhr, Genetic Marker, Henrik Krarup, HLA-DRB1*01:03, Kristine Allin, Lone Larsen, Marie Vibeke Vestergaard, Personalized Treatment, Professor Aleksejs Sazonovs, Severe Ulcerative Colitis, Tine Jess
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?